Literature DB >> 21416485

Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype.

Suman Jayadev1, David Nochlin, Parvoneh Poorkaj, Ellen J Steinbart, James A Mastrianni, Thomas J Montine, Bernardino Ghetti, Gerard D Schellenberg, Thomas D Bird, James B Leverenz.   

Abstract

OBJECTIVE: To describe the Alzheimer disease (AD)-like clinical and pathological features, including marked neurofibrillary tangle (NFT) pathology, of a familial prion disease due to a rare nonsense mutation of the prion gene (PRNP).
METHODS: Longitudinal clinical assessments were available for the proband and her mother. After death, both underwent neuropathological evaluation. PRNP was sequenced after failure to find immunopositive Aβ deposits in the proband and the documentation of prion protein (PrP) immunopositive pathology.
RESULTS: The proband presented at age 42 years with a 3-year history of progressive short-term memory impairment and depression. Neuropsychological testing found impaired memory performance, with relatively preserved attention and construction. She was diagnosed with AD and died at age 47 years. Neuropathologic evaluation revealed extensive limbic and neocortical NFT formation and neuritic plaques consistent with a Braak stage of VI. The NFTs were immunopositive, with multiple tau antibodies, and electron microscopy revealed paired helical filaments. However, the neuritic plaques were immunonegative for Aβ, whereas immunostaining for PrP was positive. The mother of the proband had a similar presentation, including depression, and had been diagnosed clinically and pathologically as AD. Reevaluation of her brain tissue confirmed similar tau and PrP immunostaining findings. Genetic analysis revealed that both the proband and her mother had a rare PRNP mutation (Q160X) that resulted in the production of truncated PrP.
INTERPRETATION: We suggest that PRNP mutations that result in a truncation of PrP lead to a prolonged clinical course consistent with a clinical diagnosis of AD and severe AD-like NFTs.
Copyright © 2010 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21416485      PMCID: PMC3114566          DOI: 10.1002/ana.22264

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family.

Authors:  B Ghetti; F Tagliavini; C L Masters; K Beyreuther; G Giaccone; L Verga; M R Farlow; P M Conneally; S R Dlouhy; B Azzarelli
Journal:  Neurology       Date:  1989-11       Impact factor: 9.910

3.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.

Authors:  T Kitamoto; K Ogomori; J Tateishi; S B Prusiner
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

4.  Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165.

Authors:  P Piccardo; B Ghetti; D W Dickson; H V Vinters; G Giaccone; O Bugiani; F Tagliavini; K Young; S R Dlouhy; C Seiler
Journal:  J Neuropathol Exp Neurol       Date:  1995-11       Impact factor: 3.685

5.  A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred.

Authors:  F Tagliavini; G Giaccone; F Prelli; L Verga; M Porro; J Q Trojanowski; M R Farlow; B Frangione; B Ghetti; O Bugiani
Journal:  Brain Res       Date:  1993-07-09       Impact factor: 3.252

Review 6.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.

Authors:  R Katzman; T Brown; P Fuld; A Peck; R Schechter; H Schimmel
Journal:  Am J Psychiatry       Date:  1983-06       Impact factor: 18.112

8.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.

Authors:  B Ghetti; P Piccardo; M G Spillantini; Y Ichimiya; M Porro; F Perini; T Kitamoto; J Tateishi; C Seiler; B Frangione; O Bugiani; G Giaccone; F Prelli; M Goedert; S R Dlouhy; F Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

Review 9.  Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles.

Authors:  B Ghetti; F Tagliavini; G Giaccone; O Bugiani; B Frangione; M R Farlow; S R Dlouhy
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

10.  Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele.

Authors:  F Tagliavini; F Prelli; M Porro; G Rossi; G Giaccone; M R Farlow; S R Dlouhy; B Ghetti; O Bugiani; B Frangione
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

View more
  39 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 2.  New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration.

Authors:  Jill S Goldman
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

3.  Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons.

Authors:  Gaël Nicolas; David Wallon; Camille Charbonnier; Olivier Quenez; Stéphane Rousseau; Anne-Claire Richard; Anne Rovelet-Lecrux; Sophie Coutant; Kilan Le Guennec; Delphine Bacq; Jean-Guillaume Garnier; Robert Olaso; Anne Boland; Vincent Meyer; Jean-François Deleuze; Hans Markus Munter; Guillaume Bourque; Daniel Auld; Alexandre Montpetit; Mark Lathrop; Lucie Guyant-Maréchal; Olivier Martinaud; Jérémie Pariente; Adeline Rollin-Sillaire; Florence Pasquier; Isabelle Le Ber; Marie Sarazin; Bernard Croisile; Claire Boutoleau-Bretonnière; Catherine Thomas-Antérion; Claire Paquet; Mathilde Sauvée; Olivier Moreaud; Audrey Gabelle; François Sellal; Mathieu Ceccaldi; Ludivine Chamard; Frédéric Blanc; Thierry Frebourg; Dominique Campion; Didier Hannequin
Journal:  Eur J Hum Genet       Date:  2015-08-05       Impact factor: 4.246

4.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

5.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

6.  Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys.

Authors:  Pedro Piccardo; Juraj Cervenak; Ming Bu; Lindsay Miller; David M Asher
Journal:  J Gen Virol       Date:  2014-04-25       Impact factor: 3.891

7.  Conserved amyloid core structure of stop mutants of the human prion protein.

Authors:  Markus Zweckstetter
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

Review 8.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

Review 9.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

10.  Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants.

Authors:  Lukasz Skora; Luis Fonseca-Ornelas; Romina V Hofele; Dietmar Riedel; Karin Giller; Jens Watzlawik; Walter J Schulz-Schaeffer; Henning Urlaub; Stefan Becker; Markus Zweckstetter
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.